Live feed16:08:47·38dINSIDERFilingvia QuantisnowEVP, Chief Development Officer Poulton Stuart was granted 896 shares and sold $3,828 worth of shares (403 units at $9.50), increasing direct ownership by 0.52% to 94,821 units (SEC Form 4) (tax withholding)ByQuantisnow·Wall Street's wire, on your screen.KPTI· Karyopharm Therapeutics Inc.Health CareOriginal source
